News
News
- Shire Announces FDA Acceptance of sBLA for CINRYZE® for Pediatric Hereditary Angioedema Use
02/15/2018 / 13:01 - GlobeNewswire - EVOTEC AG AND MARS INNOVATION ANNOUNCE FIRST FUNDED PROJECT UNDER LAB150 BRIDGE
02/15/2018 / 13:00 - GlobeNewswire - FDA Grants Approval to Shire for Technology Transfer of CINRYZE® Drug Product Manufacturing Process to Vienna, Austria Manufacturing Site
01/24/2018 / 12:01 - GlobeNewswire - FDA Grants Approval to Shire for Technology Transfer of CINRYZE® Drug Product Manufacturing Process to Vienna, Austria Manufacturing Site
01/24/2018 / 12:00 - GlobeNewswire - APEIRON and Evotec Achieve First Milestone in Immuno-oncology Alliance with Sanofi
01/08/2018 / 09:02 - GlobeNewswire - Fibrocor Therapeutics Appoints Its First President & CEO
11/28/2017 / 14:00 - GlobeNewswire - Global Toxicology Services Market 2017-2025 - Mandatory Toxicology Testing in Various Industries & Rise in Global R&D Investments
11/16/2017 / 12:07 - GlobeNewswire - Shire Receives European Approval for Label Extension of FIRAZYR® (icatibant injection) for the Symptomatic Treatment of Acute HAE Attacks in Paediatric Patients
10/26/2017 / 08:01 - GlobeNewswire - Shire Receives European Approval for Label Extension of FIRAZYR® (icatibant injection) for the Symptomatic Treatment of Acute HAE Attacks in Paediatric Patients
10/26/2017 / 08:00 - GlobeNewswire - Oak Therapeutics Announces Results of Bioequivalence Study of Company’s Oral Dissolvable Strip for Tuberculosis
10/03/2017 / 15:00 - GlobeNewswire
Real-time